JAK2 and essential thrombocythemia: We recently studied the clonal evolution of an ET patient without JAK2-V617F mutation using the single-cell exome sequencing technique, and found that several other regulatory factor genes such as SESN2 and NTRK1 may be involved in the neoplasm progression[11].